---
title: "Weekly Recap | The Campbells -1.48%, consensus target slightly above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299510295.md"
description: "The Campbells (CPB) fell 1.48% this week to close at $20.69, underperforming the S&P 500 by about 1.4 percentage points. The stock opened lower on Monday, climbed to an intraweek high of $21.83 on Wednesday, then sold off into Friday, finishing near the week’s low of $20.65. Weekly amplitude was 5.57%, with average daily volume around 6.24m shares, slightly above the 60-day median."
datetime: "2026-09-19T05:52:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299510295.md)
  - [en](https://longbridge.com/en/news/299510295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299510295.md)
generator: "portal-rs"
---

# Weekly Recap | The Campbells -1.48%, consensus target slightly above spot

## The Week

The Campbells (CPB) fell 1.48% this week to close at $20.69, underperforming the S&P 500 by about 1.4 percentage points. The stock opened lower on Monday, climbed to an intraweek high of $21.83 on Wednesday, then sold off into Friday, finishing near the week’s low of $20.65. Weekly amplitude was 5.57%, with average daily volume around 6.24m shares, slightly above the 60-day median.

## Key Events

The week was shaped mainly by capital structure and dividend discussions. Campbell’s dividend cut and weak 2027 outlook drew attention on Monday, with market participants debating whether the valuation has become too cheap. The company also debuted a new sauces lineup aimed at simplifying dinner preparation, one of the few product updates this week. Deutsche Bank maintained its hold rating on Wednesday. On Friday, Campbell’s extended its $1.85 billion credit facility maturity to April 2031 and filed the extension with the SEC. Product news took a back seat to balance sheet and payout concerns.

## Analyst Ratings

Among 21 covering institutions, 1 rates the stock buy, 13 hold, 4 underweight, 2 sell, and 1 has no opinion. The consensus rating is hold, with a consensus target of $20.79, implying roughly 0.5% upside from the current price. Target prices are wide apart, ranging from $16.00 to $41.50, reflecting a lack of agreement. Within the packaged food and meat industry, CPB ranks third out of 53 names.

## The Week Ahead

Macro data dominates the calendar next week, with the Richmond Fed composite index on 22 September, EIA crude oil inventories on 23 September, and initial jobless claims plus new home sales on 24 September. No company earnings are scheduled. The focus will be on whether the macro prints shift sentiment toward consumer staples, while the extended credit facility and related disclosures may continue to draw attention.

## In Short

CPB had a weak week, fading from its Wednesday high and closing near the bottom of the range while trailing the broader market. The analyst picture is mostly neutral, with wide target dispersion and a consensus target only modestly above spot. On the event side, the dividend cut and soft 2027 outlook weigh on sentiment, while the credit facility extension adds some balance sheet flexibility. The main question ahead is whether macro data or product updates can shift the current tone.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [CPB.US](https://longbridge.com/en/quote/CPB.US.md)

## Related News & Research

- [Is Campbell's (CPB) Cheap After Its Dividend Cut And Weak 2027 Outlook?](https://longbridge.com/en/news/298960791.md)
- [Campbell's (CPB) Cuts Its Dividend, Is The Stock Fairly Valued?](https://longbridge.com/en/news/298158113.md)
- [Campbell’s Dividend Cut May Reset the Stock, But the Turnaround Still Has to Deliver](https://longbridge.com/en/news/298348411.md)
- [Campbell's Expects 2027 Adjusted EPS Between $1.65 To $1.80](https://longbridge.com/en/news/297906417.md)
- [Top Wall Street Forecasters Revamp Campbell's Expectations Ahead Of Q4 Earnings](https://longbridge.com/en/news/297875850.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**